The global MRI-safe neurostimulation systems market is expected to have risen to about US$1,158.9 million. According to Future Market Insights, this recovery would cause the market to expand at an astounding Compound Annual Growth Rate (CAGR) of 15.3%, from its estimated US$278.5 million size in 2023 to its current size.
MRI-safe neurostimulation systems represent a revolutionary approach to treating neurological disorders. These kinds of contemporary technologies are compatible with Magnetic Resonance Imaging (MRI) exams and can offer customized brain stimulation. This has significant advantages for ongoing patient monitoring and care.
Elevate Knowledge: Obtain Your Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4978
When compared to traditional medical therapy, such as MRI-Safe, implantable neurostimulation systems show better tolerability, success rates, and are less invasive. Applications for MRI-safe neurostimulation devices include Parkinson’s disease, hearing loss, obesity, gastroparesis, chronic pain, and epilepsy. Furthermore, because neurological illnesses are becoming more common, it is expected that the U.S. market for implantable neurostimulation devices would expand significantly over the next few years. Patients can now get an MRI without worrying about any potential negative effects thanks to the development of MRI-safe neurostimulation technology. Furthermore, it is projected that this will increase demand for MRI-safe neurostimulation devices, hence expanding market revenue creation.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-4978
Competition Landscape:
The top businesses in the global market for MRI-safe neurostimulation systems include Boston Scientific, Sorin, Medtronic Inc, Cyberonics, Inc., AADCO Medical Inc., and Biotronik, among others.
Furthermore, a number of significant industry participants in the global MRI-Safe Neurostimulation Systems Market are currently concentrating more on forming alliances, purchasing businesses, and/or engaging in joint ventures in order to increase the size of their individual customer bases.
An important general trend is that enterprises in the market for MRI-safe neurostimulation devices are now searching for nations with advantageous policies in order to establish themselves internationally. Nowadays, companies in the industry are trying to start strategies like CSR initiatives and targeted marketing. Businesses are increasingly choosing to do business in nations with advantageous legislation in an effort to become globally recognized. It enables these companies to cut expenses while hiring industry experts at every pivotal juncture in the operation of their own enterprises.
- In December 2023, Boston Scientific, a manufacturer of medical devices used in interventional medical specialties, constructed a new manufacturing and supply chain facility in Johns Creek, Georgia. The $62.5 million investment is expected to bring roughly 340 new jobs to Fulton County over the next seven years.
- In January 2023, Nevro Corp. a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced a series of data presentations supporting the use of the company’s HFX™ 10 kHz Therapy for patients with chronic pain.
- In July 2023, Boston Scientific has a mystical company behind an ambitious plan for building a $170 million facility in Maple Grove, a project that will significantly help in the expansion of the medical technology company’s presence in the city and will thus lead in the creation of more than 175 new jobs.
Key Companies Profiled:
- Medtronic Inc.
- Cyberonics, Inc.
- AADCO Medical Inc.
- Boston Scientific
- Sorin
- St. Jude Medical
- Biotronik
- Codman & Shurtleff’s
- Nevro Corporation
- Boston Scientific Corporation
Key Segments Profiled in the MRI-Safe Neurostimulation Systems Market
By Product:
- Implantable
- Transcutaneous
By Application:
- Spinal Cord Stimulation (SCS)
- Peripheral Nerve Stimulation
- Intracranial Stimulation
- Deep Brain Stimulation
- Motor Cortex Stimulation
- Sensory Nerve Stimulation
- Vagus Nerve Stimulation
By End User:
- Hospitals & Clinics
- Diagnostic Labs and Centers
- Ambulatory Surgical Centers
- Research Laboratories
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East and Africa
Unlock In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/4978
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube